Impact of the WHO depression guideline on patient care by psychiatrists: A randomized controlled trial

European Psychiatry

Volumn 23, Issue 6, 2008, Pages 403-408

  Linden, Michel ^a   Westram, Anja ^a   Schmidt, Lutz G ^b   Haag, Clemenz ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Organon GmbH Germany   (Germany)

Author keywords

Continuing medical education; Depression; Evidence based medicine; Psychiatrists; Randomized controlled trial; Treatment guidelines

Indexed keywords

MIRTAZAPINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DOCTOR PATIENT RELATION; FEMALE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MENTAL STRESS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PRIVATE PRACTICE; PSYCHIATRIST; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION;

ADULT; AFFECT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; FEMALE; GERMANY; HUMANS; INSERVICE TRAINING; MALE; MIANSERIN; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRY; WORLD HEALTH ORGANIZATION;

EID: 51249094299     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2008.04.001     Document Type: Article

References (34)

1. Azocar F., Cuffel B., Goldmann W., and McCarter L. The impact of evidence-based guideline dissemination for the assessment and treatment of major depression in a managed behavioral health care organization. J Behav Health Serv Res 30 Pt 1 (2003) 109-118
2. Baker R., Reddish S., Robertson N., Hearnshaw H., and Jones B. Randomised controlled trial of tailored strategies to implement guidelines for the management of patients with depression in general practice. Br J Gen Pract 51 (2001) 737-741
3. Burvill P.W., Mowry W.D., and Hall W.D. Quantification of physical illness in psychiatric research in the elderly. Int J Geriatr Psychiatry 5 (1990) 161-170
4. Callahan C.M., Hendrie H.C., Dittus R., Brater D.C., Hui S.L., and Tierney W.M. Proving treatment of late life depression in primary care: a randomized clinical trial. J Am Geriatr Soc 42 (1994) 839-846
5. Clade H. Medizinische Leitlinien. Entscheidungshilfe für Arzt und Patienten. Juristen warnen davor, evidenzbasierte medizinische Leitlinien als Disziplinierungsinstrumente gegen Ärzte einzusetzen. Deutsches Ärzteblatt 98 (2001) B247-B248
6. Croudace T., Evans J., Harrison G., Sharp D.J., Wilkinson E., McCann G., et al. Impact of the ICD-10 primary health care (PHC) diagnostic and management guidelines for mental disorders on detection and outcome in primary care. Br J Psychiatry 182 (2003) 20-30
7. Fähndrich E., and Linden M. Zur Reliabilität und Validität der Stimmungsmessung mit der Visuellen Ana-log-skala (VAS). Pharmacopsychiatria 15 (1982) 90-94
8. Gore A. Speech to the Democratic National Convention. USA Today (August; 2000) 18
9. Greco P.J., and Eisenberg J.M. Changing physicians practices. N Engl J Med 329 (1993) 1271-1274
10. Keitner G.I., Ryan C.E., and Solomon D.A. Realistic expectations and a disease management model for depressed patients with persistent symptoms. J Clin Psychiatry 67 (2006) 1412-1421
11. Koller M., and Lorenz W. Ziele des Heilens und Konzepte von Outcome in der modernen Medizin. Recht Politik Gesundheitswesen 8 (2002) 18-25
12. Langhoff C, Baer T, Zubraegel D, Linden M. The therapeutic alliance and treatment outcome in cognitive behaviour therapy of generalized anxiety disorders. J Cogn Psychother (in press).
13. Lasek R., and Müller-Oerlinghausen B. Evidence Based Medicine. Ein neues Zeitalter der Medizin? Limitierung der "Evidence Based Medicine", Mangel an "Evidence" und Probleme bei der Umsetzung von Studienergebnissen in die Praxis. Deutsches Ärzteblatt 95 (1998) B1432-B1434
14. Lin E.H.B., Simon G.E., Katzelnick D.J., and Pearson S.D. Does physician education on depression management improve treatment in primary care?. J Gen Intern Med 16 (2001) 614-619
15. Linden M. Der Einfluss von Leitlinien, Standards und ökonomischen Vorgaben auf medizinische Entscheidungsprozesse. Z Arztl Fortbild Qualität Gesundheitswesen 98 (2004) 200-205
16. Linden M. Leitlinien und die Psychologie medizinischer Entscheidungsprozesse bei der Behandlung depressiver Erkrankungen. Fortschr Neurol Psychiatr 73 (2005) 249-258
17. Linden M., Dierkes W., and Munz T. Non-pharmacological treatment of psychiatrists in addition to the prescribing of an antidepressant drug. Eur Psychiatry 22 (2007) 419-426
18. Linden M., Gothe H., Dittmann R.W., and Schaaf B. Early termination of antidepressant drug treatment. J Clin Psychopharmacol 20 (2000) 523-530
19. Linden M., Osterheider M., Nickelsen T., and Schaaf B. Three types of early termination of antidepressant drug treatment. Int Clin Psychopharmacol 8 (1993) 345-346
20. Linden M., and Schotte K. A randomized controlled clinical trial on dosage selection and treatment outcome with doxepin comparing "guideline exposed" and "guideline naive" physicians. Pharmacopsychiatry 40 (2007) 77-81
21. National Guideline Clearinghouse. URL: (2006). http://www.guideline.gov/
22. National Institute of Mental Health. Clinical Global Impressions. In: Guy W. (Ed). ECDEU assessment in psychopharmacology. Revised ed (1976), Rockville, MD 217-222
23. Schaaf B., Linden M., and Weber H.J. An investigation of the representativity of neuropsychiatrists and their patients in a drug utilization observation study on Fluoxetine. Pharmacopsychiatry 30 (1997) 44-51
24. Schmidt K. Zum Teufel mit den Expertokraten. Münch Med Wschr 144 (2002) 48-49
25. Schotte K., and Linden M. Correlates of low-dosage treatment with antidepressants by psychiatrists and general practitioners. Pharmacoepidemiology and Drug Safety 16 (2007) 675-680
26. Thompson C., Kinmonth A.L., Stevens L., Peveler R.C., Stevens A., Ostler K.J., et al. Effects of a clinical-practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire depression project randomised controlled trial. Lancet 355 (2000) 185-191
27. Toprac M.G., Dennehy E.B., Carmody T.J., Crismon M.L., Miller A.L., Trivedi M.H., et al. Implementation of the Texas Medication Algorithm Project patient and family education program. J Clin Psychiatry 67 (2006) 1362-1372
28. Upton M.W.M., Evans M., Goldberg D.P., and Sharp D.J. Evaluation of ICD-10 PHC mental health guidelines in detecting and managing depression in primary care. Br J Psychiatry 175 (1999) 476-482
29. Woolf S.H., Grol R., Hutchinson A., Eccles M., and Grimshaw J. Potential benefits, limitations, and harms of clinical guidelines. BMJ 318 (1999) 527-530
30. World Health Organization (WHO). Diagnostic and management guidelines for mental disorders in primary care: ICD - 10 Chapter V Primary care version (1996), WHO/Hogrefe & Huber Publishers, . Göttingen, Germany 24-25
31. World Health Organization (WHO). Information package, programme guidelines mental disorders in primary care (1998), WHO/MSA/MNH/EAC/98.1, Genf, Switzerland
32. Worrall G., Angel J., Chaulk P., and Robbins M. Effectiveness of an educational strategy to improve family physicians detection and management of depression: a randomized controlled trial. CMAJ 161 Pt 1 (1999) 37-40
33. Zimmermann M., Mattia J.L., and Posternak M.A. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?. Am J Psychiatry 159 (2002) 469-473
34. Zurhorst G. Eminenz-basierte, Evidenz-basierte oder Ökologisch-basierte Psychotherapie?. Psychotherapeutenjournal 97 (2003) 97-104